PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer
Clinical trial NCT03179410 · COMPLETED
Trial details
- NCT number
- NCT03179410
- Sponsor
- Andrew J. Armstrong, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2020-01-09
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.